Analysis of Effectiveness and Safety of Teclistamab in Relapsed and Refractory Multiple Myeloma Patients

NCT06062537 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
200
Enrollment
NETWORK
Sponsor class

Conditions

Sponsor

Intergroupe Francophone du Myelome

Collaborators